Using Continuous Glucose Monitoring for Diabetes Mellitus in Pregnancy
Poor glycemic control in pregnant women with diabetes is closely related to the increased risk of adverse pregnancy outcomes. Therefore, it is very important to achieve strict glycemic control to improve maternal and neonatal outcomes. This chapter focuses on the introduction of the clinical application of continuous glucose monitoring (CGM) in pregnant women with diabetes mellitus. We will briefly introduce the clinical characteristics, diagnostic criteria, and glycemic control goals of diabetes mellitus in pregnancy. We will then classify and analyze the recent developments of CGM application in the clinical management of diabetes in pregnancy. We will use four typical cases as illustrations as how to use CGM technology to detect the glycemic variability in pregnant women with diabetes, as well as how to use the CGM data for individualized treatment, and how to improve pregnancy outcomes by CGM technology. The final section offers a clinical and academic prospective of CGM application in this area.
KeywordsContinuous glucose monitoring Pregestational diabetes mellitus Gestational diabetes mellitus Maternal and neonatal outcomes
- 1.Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Group of Pregnancy with Diabetes Mellitus, Chinese Society of Perinatal Medicine, Chinese Medical Association, Obstetrics Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association, Group of Pregnancy with Diabetes Mellitus Chinese Society of Perinatal Medicine Chinese Medical Association. Diagnosis and therapy guideline of pregnancy with diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi. 2014;49:561–9. https://doi.org/10.3760/cma.j.issn.0529-567x.2014.08.001.CrossRefGoogle Scholar
- 2.HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. https://doi.org/10.1056/NEJMoa0707943.CrossRefGoogle Scholar
- 4.Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ, HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35:780–6. https://doi.org/10.2337/dc11-1790.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55:936–47. https://doi.org/10.1007/s00125-012-2455-y.CrossRefGoogle Scholar
- 7.Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66 Suppl 2:14-20. https://doi.org/10.1159/000371628.
- 8.Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, Zhu D, Chen L, Chen L, Guo L, Guo X, Ji Q, Li Q, Li X, Liu J, Ran X, Shan Z, Shi L, Song G, Yang L, Yang Y, Yang W, Chinese Diabetes Society. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32:442–58. https://doi.org/10.1002/dmrr.2827.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva AD, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82. https://doi.org/10.2337/dc09-1848.CrossRefPubMedCentralGoogle Scholar
- 10.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1:62-9. https://doi.org/10.2337/dc11-S062.
- 11.WHO Guidelines Approved by the Guidelines Review Committee. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013.Google Scholar
- 12.American Diabetes Association. 12. Management of diabetes in pregnancy. Diabetes Care. 2016;39 Suppl 1:94-8. https://doi.org/10.2337/dc16-S015.
- 13.American Diabetes Association. 13. Management of diabetes in pregnancy. Diabetes Care. 2017;40 Suppl 1:114-9. https://doi.org/10.2337/dc17-S016.
- 14.Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2012). Chin Med J. 2012;125:4167–74. https://doi.org/10.3760/cma.j.issn.0366-6999.2012.23.002.CrossRefGoogle Scholar
- 17.Dalfrà MG, Chilelli NC, Di Cianni G, Mello G, Lencioni C, Biagioni S, Scalese M, Sartore G, Lapolla A. Glucose fluctuations during gestation: an additional tool for monitoring pregnancy complicated by diabetes. Int J Endocrinol. 2013;2013:279021. https://doi.org/10.1155/2013/279021.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technol Ther. 2011;13:1109–13. https://doi.org/10.1089/dia.2011.0081.CrossRefPubMedGoogle Scholar
- 21.Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple R, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34:406–11. https://doi.org/10.2337/dc10-1796.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, Simmons D, Dunger DB, Nodale M, Wilinska ME, Amiel SA, Hovorka R. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34:2527–9. https://doi.org/10.2337/dc11-1430.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19:155–63. https://doi.org/10.1089/dia.2016.0421.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TR, Trimble ER, Coustan DR, Hadden DR, Hod M, Oats JJ, Persson B, HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care. 2012;35:574–80. https://doi.org/10.2337/dc11-1687.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Secher AL, Stage E, Ringholm L, Barfred C, Damm P, Mathiesen ER. Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with type 1 diabetes-an observational study. Diabet Med. 2014;31:352–6. https://doi.org/10.1111/dme.12383.CrossRefPubMedGoogle Scholar